111 ( (YI) ) has issued an update.
111, Inc. announced its financial results for the fourth quarter and fiscal year 2024, marking a significant milestone with its first-ever annual operating profit and positive operating cash flow. Despite a challenging macroeconomic environment and healthcare reforms, the company improved its bottom line by RMB332.7 million year-over-year and reduced operating expenses as a percentage of revenues. The company achieved net revenues of RMB14.4 billion and a gross segment profit of RMB829.2 million for the fiscal year, despite slight decreases from the previous year. The results underscore the company’s strategic execution and operational efficiency improvements, positioning it as a resilient player in the tech-enabled healthcare e-commerce sector.
More about 111
111, Inc. is a leading tech-enabled healthcare platform company based in Shanghai, China. It focuses on reshaping the healthcare industry’s value chain through digital empowerment, targeting both upstream and downstream sectors.
YTD Price Performance: 76.57%
Average Trading Volume: 41,862
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $84.12M
Learn more about YI stock on TipRanks’ Stock Analysis page.